These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11182222)

  • 1. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
    Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
    Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
    Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
    Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
    Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
    Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco reduces membrane HLA class I that is restored by transfection with transporter associated with antigen processing 1 cDNA.
    Fine CI; Han CD; Sun X; Liu Y; McCutcheon JA
    J Immunol; 2002 Nov; 169(10):6012-9. PubMed ID: 12421988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
    Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
    Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.
    Liu Y; Komohara Y; Domenick N; Ohno M; Ikeura M; Hamilton RL; Horbinski C; Wang X; Ferrone S; Okada H
    Cancer Immunol Immunother; 2012 Jun; 61(6):789-801. PubMed ID: 22065046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranscriptional regulation of human leukocyte antigen G during human extravillous cytotrophoblast differentiation.
    Copeman J; Han RN; Caniggia I; McMaster M; Fisher SJ; Cross JC
    Biol Reprod; 2000 Jun; 62(6):1543-50. PubMed ID: 10819754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analysis of HLA class I subunits expression in breast cancer tissues.
    Pistillo MP; Nicolò G; Salvi S; Capanni P; Perdelli L; Pasciucco G; Ferrara GB
    Hum Immunol; 2000 Apr; 61(4):397-407. PubMed ID: 10715517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I antigen downregulation by interleukin (IL)-10 is predominantly governed by NK-kappaB in the short term and by TAP1+2 in the long term.
    Terrazzano G; Romano MF; Turco MC; Salzano S; Ottaiano A; Venuta S; Fontana S; Manzo C; Zappacosta S; Carbone E
    Tissue Antigens; 2000 Apr; 55(4):326-32. PubMed ID: 10852384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
    Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
    Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.
    Wang Z; Margulies L; Hicklin DJ; Ferrone S
    Tissue Antigens; 1996 May; 47(5):382-90. PubMed ID: 8795138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
    Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
    Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell receptor-mediated recognition of HLA-E.
    García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
    Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.